Detalhe da pesquisa
1.
Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme.
Eur Respir J
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575162
2.
Patient adherence and response time in electronic patient-reported outcomes: insights from three longitudinal clinical trials.
Qual Life Res
; 33(6): 1691-1706, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598132
3.
The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
Respir Res
; 24(1): 121, 2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131265
4.
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 149(4): 1309-1317.e12, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599979
5.
Benralizumab for the Prevention of COPD Exacerbations.
N Engl J Med
; 381(11): 1023-1034, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112385
6.
Alternative views on setting clinical trial futility criteria.
J Biopharm Stat
; 24(5): 976-93, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24933121
7.
Benralizumab in Severe Eosinophilic Asthma and Chronic Rhinosinusitis with Nasal Polyps: The Real-World, Multi-Country RANS Observational Study.
J Asthma Allergy
; 17: 313-324, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38595692
8.
Impact of patient support programmes among patients with severe asthma treated with biological therapies: a systematic literature review and indirect treatment comparison.
BMJ Open Respir Res
; 11(1)2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697674
9.
Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
Respir Med
; : 107611, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570145
10.
The Bronchiectasis Exacerbation Diary: a novel patient-reported outcome for non-cystic fibrosis bronchiectasis.
ERJ Open Res
; 9(3)2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143836
11.
Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
Ann Otol Rhinol Laryngol
; 132(12): 1638-1648, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271980
12.
Assessing asthma symptoms in children: qualitative research supporting the development of the Pediatric Asthma Diary-Child (PAD-C) and Pediatric Asthma Diary-Observer (PAD-O).
J Patient Rep Outcomes
; 7(1): 104, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37863864
13.
Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary.
Int Forum Allergy Rhinol
; 12(8): 996-1005, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34921526
14.
The impact of neurocognitive impairment on occupational recovery of clinically stable patients with bipolar disorder: a prospective study.
Bipolar Disord
; 13(4): 323-33, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21843272
15.
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies.
Lancet Respir Med
; 8(2): 158-170, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31575508
16.
Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.
J Asthma Allergy
; 11: 181-192, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30510434
17.
Time reproduction performance is associated with age and working memory in high-functioning youth with autism spectrum disorder.
Autism Res
; 8(1): 29-37, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078724